Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Receivables - Net: 2017

Historic Receivables - Net for KalVista Pharmaceuticals (KALV) over the last 1 years, with Oct 2017 value amounting to $7.3 million.

  • KalVista Pharmaceuticals' Receivables - Net was N/A to $7.3 million in Q4 2017 from the same period last year, while for Oct 2017 it was $7.3 million, marking a year-over-year change of. This contributed to the annual value of $7.3 million for FY2017, which is N/A change from last year.
  • Per KalVista Pharmaceuticals' latest filing, its Receivables - Net stood at $7.3 million for Q4 2017, which was down 0.00% from $7.3 million recorded in Q3 2017.
  • Over the past 5 years, KalVista Pharmaceuticals' Receivables - Net peaked at $7.3 million during Q2 2017, and registered a low of $7.3 million during Q2 2017.
  • Over the past 1 years, KalVista Pharmaceuticals' median Receivables - Net value was $7.3 million (recorded in 2017), while the average stood at $7.3 million.